EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021

Dominika Stastna, Jiri Drahota, Michal Lauer, Aneta Mazouchova, Ingrid Menkyova, Jana Adamkova, Radek Ampapa, Michal Dufek, Marketa Grunermelova, Pavel Hradilek, Eva Kubala Havrdova, Jan Mares und 9 weitere

Biomedical Papers · 12.09.2024 · 168 (3) · 262-270

DOI: 10.5507/bp.2023.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Papers, erschienen am 12.09.2024. Verfasst von Dominika Stastna und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital,…. Hauptthemen laut MEDLINE: Registries, Multiple Sclerosis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RegistriesMultiple SclerosisHumansCzech RepublicMaleFemaleAdultImmunosuppressive AgentsImmunologic Factors

Stichwörter der Autor:innen

disease-modifying therapyepidemiologyhigh-efficacy therapymultiple sclerosisplatform therapyreal-world dataregistrytreatment initiation

Substanzen

Immunosuppressive AgentsImmunologic Factors

Autor:innen und Institutionen

  • Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
  • Endowment Fund IMPULS, Prague, Czech Republic.
  • Department of Economic Statistics, Prague University of Economics and Business, Prague, Czech Republic.
  • 2nd Department of Neurology, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic.
  • Department of Neurology, Hospital Ceske Budejovice, Ceske Budejovice, Czech Republic.
  • Department of Neurology, Hospital of Jihlava, Jihlava, Czech Republic.

Zitieren

APA

Stastna, D., Drahota, J., Lauer, M., Mazouchova, A., Menkyova, I., Adamkova, J., Ampapa, R., Dufek, M., Grunermelova, M., Hradilek, P., Kubala Havrdova, E., Mares, J., Martinkova, A., Pavelek, Z., Peterka, M., Recmanova, E., Rockova, P., Stetkarova, I., Stourac, P., …, & Horakova, D. (2024). The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021. Biomedical Papers, 168(3), 262-270. https://doi.org/10.5507/bp.2023.015

Vancouver

Stastna D, Drahota J, Lauer M, Mazouchova A, Menkyova I, Adamkova J, et al. The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021. Biomedical Papers. 2024;168(3):262-270. doi:10.5507/bp.2023.015

BibTeX
@article{Stastna2024,
  author = {Stastna, Dominika and Drahota, Jiri and Lauer, Michal and Mazouchova, Aneta and Menkyova, Ingrid and Adamkova, Jana and Ampapa, Radek and Dufek, Michal and Grunermelova, Marketa and Hradilek, Pavel and Kubala Havrdova, Eva and Mares, Jan and Martinkova, Alena and Pavelek, Zbysek and Peterka, Marek and Recmanova, Eva and Rockova, Petra and Stetkarova, Ivana and Stourac, Pavel and Vachova, Marta and Horakova, Dana},
  title = {The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021},
  journal = {Biomedical Papers},
  year = {2024},
  volume = {168},
  number = {3},
  pages = {262--270},
  doi = {10.5507/bp.2023.015}
}
Kostenlos starten →